Healthcare -
Biotechnology - NASDAQ - US
$ 1.16
-2.52 %
$ 104 M
Market Cap
-0.94
P/E
IMUX - COST OF REVENUE
Cost of Revenue IMUX - Immunic, Inc.
111 K
LAST VALUE
14.28%
2 YEAR CAGR
49.23%
5 YEAR CAGR
0.00%
10 YEAR CAGR